GRPH insider filings
Graphite Bio, Inc. — 44 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-08-01. Screen GRPH transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for GRPH between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Graphite Bio, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-08-01 | 4 | Drapkin Kimberlee C — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2023-07-21 | 4 | Viney Joanne L. — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2023-07-21 | 4 | Porteus Matthew — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2023-07-21 | 4 | Carlo Rizzuto — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2023-07-21 | 4 | Bassan Abraham — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2023-07-21 | 4 | Shah Smital — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2023-07-21 | 4 | Jerel Davis — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2023-07-21 | 4 | Hege Kristen — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2023-07-21 | 4 | KARSEN PERRY A — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2023-07-21 | 4 | JIMENEZ JOSEPH — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2023-02-23 | 4 | Young Alethia — Chief Financial Officer | Grant/award (A): 220,000 (derivative) @ $0 | EDGAR |
| 2023-02-23 | 4 | Lehrer-Graiwer Joshua — PRESIDENT AND CEO, Director | Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2022-06-22 | 4 | Viney Joanne L. — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2022-06-22 | 4 | Porteus Matthew — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2022-06-22 | 4 | Carlo Rizzuto — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2022-06-22 | 4 | Bassan Abraham — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2022-06-22 | 4 | Shah Smital — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2022-06-22 | 4 | Jerel Davis — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2022-06-22 | 4 | Hege Kristen — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2022-06-22 | 4 | KARSEN PERRY A — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2022-06-22 | 4 | JIMENEZ JOSEPH — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2022-04-13 | 4 | Gutry Phil — CHIEF BUSINESS OFFICER | Purchase (P): 5,000 @ $4.01 | EDGAR |
| 2022-04-13 | 4 | Samsara BioCapital, L.P. — 10% owner AKKARAJU SRINIVAS — 10% owner | Purchase (P): 74,464 @ $4.07 · Purchase (P): 350,000 @ $4.08 | EDGAR |
| 2022-04-05 | 4 | Young Alethia — Chief Financial Officer | Grant/award (A): 350,000 (derivative) @ $0 | EDGAR |
| 2022-02-18 | 4 | Lehrer-Graiwer Joshua — PRESIDENT AND CEO, Director | Grant/award (A): 650,000 (derivative) @ $0 | EDGAR |
| 2022-02-18 | 4 | Gutry Phil — CHIEF BUSINESS OFFICER | Grant/award (A): 115,000 (derivative) @ $0 | EDGAR |
| 2022-01-25 | 4 | Samsara BioCapital, L.P. — 10% owner AKKARAJU SRINIVAS — 10% owner | Purchase (P): 100,000 @ $8.99 · Purchase (P): 23,000 @ $8.70 | EDGAR |
| 2022-01-21 | 4 | Samsara BioCapital, L.P. — 10% owner AKKARAJU SRINIVAS — 10% owner | Purchase (P): 54,565 @ $9.24 · Purchase (P): 43,105 @ $8.92 | EDGAR |
| 2021-12-20 | 4 | Samsara BioCapital, L.P. — 10% owner AKKARAJU SRINIVAS — 10% owner | Purchase (P): 22,329 @ $10.19 | EDGAR |
| 2021-11-24 | 4 | Samsara BioCapital, L.P. — 10% owner AKKARAJU SRINIVAS — 10% owner | Purchase (P): 201,685 @ $10.15 | EDGAR |
| 2021-10-15 | 4 | Samsara BioCapital, L.P. — 10% owner AKKARAJU SRINIVAS — 10% owner | Purchase (P): 45,400 @ $13.22 · Purchase (P): 3,100 @ $12.50 · Purchase (P): 2,300 @ $12.49 | EDGAR |
| 2021-10-08 | 4 | Samsara BioCapital, L.P. — 10% owner AKKARAJU SRINIVAS — 10% owner | Purchase (P): 61,475 @ $13.83 · Purchase (P): 9,021 @ $14.94 · Purchase (P): 75,000 @ $13.12 | EDGAR |
| 2021-07-01 | 4 | Stultz Katherine V — CHIEF OPERATING OFFICER | Conversion (C): 8,126 · Grant/award (A): 99,753 (derivative) @ $0 · Grant/award (A): 19,763 (derivative) @ $5.06 · Grant/award (A): 209,846 (derivative) @ $0 · Grant/award (A): 89,934 (derivative) @ $0 · Conversion (C): 19,763 (derivative) @ $0 | EDGAR |
| 2021-07-01 | 4 | Shah Smital — Director | Purchase (P): 5,882 @ $17 · Grant/award (A): 93,585 (derivative) @ $0 | EDGAR |
| 2021-07-01 | 4 | Lehrer-Graiwer Joshua — PRESIDENT AND CEO, Director | Option exercise (M): 374,013 @ $0.30 · Conversion (C): 8,126 · Grant/award (A): 374,013 (derivative) @ $0 · Option exercise (M): 374,013 (derivative) @ $0 · Grant/award (A): 19,763 (derivative) @ $5.06 · Grant/award (A): 795,196 (derivative) @ $0 · +2 more | EDGAR |
| 2021-07-01 | 4 | Jerel Davis — Director, 10% owner | Conversion (C): 12,343,727 · Conversion (C): 1,527,719 · Purchase (P): 180,000 @ $17 · Conversion (C): 30,019,945 (derivative) · Conversion (C): 3,715,415 (derivative) | EDGAR |
| 2021-07-01 | 4 | Versant Venture Capital VI, L.P. — 10% owner Versant Ventures VI GP, L.P. — 10% owner Versant Ventures VI GP-GP, LLC — 10% owner Versant Vantage II, L.P. — 10% owner Versant Vantage II GP, L.P. — 10% owner Versant Vantage II GP-GP, LLC — 10% owner | Conversion (C): 12,343,727 · Conversion (C): 1,527,719 · Purchase (P): 180,000 @ $17 · Conversion (C): 30,019,945 (derivative) · Conversion (C): 3,715,415 (derivative) | EDGAR |
| 2021-07-01 | 4 | Gutry Phil — CHIEF BUSINESS OFFICER | Option exercise (M): 91,406 @ $0.30 · Option exercise (M): 3,383 @ $6.11 · Conversion (C): 8,126 · Grant/award (A): 91,406 (derivative) @ $0 · Option exercise (M): 91,406 (derivative) @ $0 · Grant/award (A): 19,763 (derivative) @ $5.06 · +4 more | EDGAR |
| 2021-07-01 | 4 | KARSEN PERRY A — Director | Conversion (C): 8,126 · Grant/award (A): 74,794 (derivative) @ $0 · Grant/award (A): 19,763 (derivative) @ $5.06 · Grant/award (A): 18,698 (derivative) @ $0 · Conversion (C): 19,763 (derivative) @ $0 | EDGAR |
| 2021-07-01 | 4 | Samsara BioCapital, L.P. — 10% owner 436, L.P. — 10% owner AKKARAJU SRINIVAS — 10% owner | Conversion (C): 6,167,763 · Conversion (C): 741,107 · Conversion (C): 22,753 · Purchase (P): 485,000 @ $17 · Purchase (P): 15,000 @ $17 · Conversion (C): 15,000,000 (derivative) @ $0 · +2 more | EDGAR |
| 2021-07-01 | 4 | JIMENEZ JOSEPH — Director | Option exercise (M): 49,876 @ $0.30 · Conversion (C): 8,126 · Grant/award (A): 49,876 (derivative) @ $0 · Option exercise (M): 49,876 (derivative) @ $0 · Grant/award (A): 19,763 (derivative) @ $5.06 · Grant/award (A): 12,469 (derivative) @ $0 · +1 more | EDGAR |
| 2021-06-28 | 4 | Carlo Rizzuto — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2021-06-28 | 4 | Bassan Abraham — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2021-06-28 | 4 | Jerel Davis — Director, 10% owner | Grant/award (A): 10,000,000 (derivative) @ $1 · Grant/award (A): 3,715,415 (derivative) @ $5.06 · Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Graphite Bio, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-10-28 | 8-K | 2.02 — Results of Operations and Financial Condition ? 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-02 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-06-12 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-24 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-12 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-11-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-08 | 8-K | 8.01 — Other Events | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=GRPH returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs